Signaling Mechanisms and Vascular Function in Diabetes Mellitus

NCT00761852 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus

Interventions

DRUG: Ruboxistaurin
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]